APOC / AQUE (Systemic Somatostatin Analogs)
Neuroendocrine Tumors and Acromegaly
Phase 1Ongoing Clinical Development
Key Facts
Indication
Neuroendocrine Tumors and Acromegaly
Phase
Phase 1
Status
Ongoing Clinical Development
Company
About Ascil Biopharm
Ascil Biopharm is a Barcelona-based biotech company with a dual business model: developing its own innovative drug delivery systems and providing contract development and manufacturing (CDMO) services. The company specializes in complex formulations for systemic and locoregional delivery, with a clinical-stage pipeline and a portfolio of proprietary medical devices. Its strategy leverages European grant funding and aims to address unmet medical needs through enhanced drug efficacy, safety, and patient convenience.
View full company profile